Logo image of GPI.MI

GPI SPA (GPI.MI) Stock Fundamental Analysis

BIT:GPI - Euronext Milan - IT0005221517 - Common Stock - Currency: EUR

15.44  +1.22 (+8.58%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GPI. GPI was compared to 11 industry peers in the Health Care Technology industry. While GPI belongs to the best of the industry regarding profitability, there are concerns on its financial health. GPI is valued quite cheap, while showing a decent growth score. This is a good combination! Finally GPI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

GPI had positive earnings in the past year.
GPI had a positive operating cash flow in the past year.
In the past 5 years GPI has always been profitable.
Each year in the past 5 years GPI had a positive operating cash flow.
GPI.MI Yearly Net Income VS EBIT VS OCF VS FCFGPI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of GPI (10.91%) is better than 90.91% of its industry peers.
With an excellent Return On Equity value of 33.74%, GPI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GPI has a Return On Invested Capital (4.54%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for GPI is significantly below the industry average of 9.32%.
The last Return On Invested Capital (4.54%) for GPI is above the 3 year average (3.61%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.91%
ROE 33.74%
ROIC 4.54%
ROA(3y)4.3%
ROA(5y)3.67%
ROE(3y)13.36%
ROE(5y)13.06%
ROIC(3y)3.61%
ROIC(5y)4.65%
GPI.MI Yearly ROA, ROE, ROICGPI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

With an excellent Profit Margin value of 20.96%, GPI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
GPI's Profit Margin has improved in the last couple of years.
The Operating Margin of GPI (7.40%) is comparable to the rest of the industry.
GPI's Operating Margin has improved in the last couple of years.
GPI has a Gross Margin (71.31%) which is in line with its industry peers.
In the last couple of years the Gross Margin of GPI has remained more or less at the same level.
Industry RankSector Rank
OM 7.4%
PM (TTM) 20.96%
GM 71.31%
OM growth 3Y0.35%
OM growth 5Y3.23%
PM growth 3Y83.16%
PM growth 5Y39.62%
GM growth 3Y-0.12%
GM growth 5Y0.09%
GPI.MI Yearly Profit, Operating, Gross MarginsGPI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

GPI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GPI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GPI has more shares outstanding
Compared to 1 year ago, GPI has an improved debt to assets ratio.
GPI.MI Yearly Shares OutstandingGPI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
GPI.MI Yearly Total Debt VS Total AssetsGPI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that GPI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GPI (1.32) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.79 indicates that GPI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.79, GPI is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.76
WACC5.96%
GPI.MI Yearly LT Debt VS Equity VS FCFGPI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

GPI has a Current Ratio of 1.37. This is a normal value and indicates that GPI is financially healthy and should not expect problems in meeting its short term obligations.
GPI has a Current ratio of 1.37. This is comparable to the rest of the industry: GPI outperforms 54.55% of its industry peers.
A Quick Ratio of 1.32 indicates that GPI should not have too much problems paying its short term obligations.
GPI has a Quick ratio of 1.32. This is in the better half of the industry: GPI outperforms 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.32
GPI.MI Yearly Current Assets VS Current LiabilitesGPI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1789.47% over the past year.
The Earnings Per Share has been growing by 43.78% on average over the past years. This is a very strong growth
The Revenue has grown by 16.92% in the past year. This is quite good.
The Revenue has been growing by 15.94% on average over the past years. This is quite good.
EPS 1Y (TTM)1789.47%
EPS 3Y80.87%
EPS 5Y43.78%
EPS Q2Q%169.57%
Revenue 1Y (TTM)16.92%
Revenue growth 3Y15.3%
Revenue growth 5Y15.94%
Sales Q2Q%9.98%

3.2 Future

GPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.34% yearly.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y44.86%
EPS Next 2Y42.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.47%
Revenue Next 2Y6.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GPI.MI Yearly Revenue VS EstimatesGPI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
GPI.MI Yearly EPS VS EstimatesGPI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.30, the valuation of GPI can be described as very cheap.
Based on the Price/Earnings ratio, GPI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.04. GPI is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 20.45, which indicates a rather expensive current valuation of GPI.
Based on the Price/Forward Earnings ratio, GPI is valued a bit cheaper than 63.64% of the companies in the same industry.
GPI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.3
Fwd PE 20.45
GPI.MI Price Earnings VS Forward Price EarningsGPI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GPI indicates a rather cheap valuation: GPI is cheaper than 81.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.43
GPI.MI Per share dataGPI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GPI has a very decent profitability rating, which may justify a higher PE ratio.
GPI's earnings are expected to grow with 42.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)0.1
EPS Next 2Y42.34%
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.51%, GPI has a reasonable but not impressive dividend return.
GPI's Dividend Yield is a higher than the industry average which is at 3.63.
Compared to an average S&P500 Dividend Yield of 2.35, GPI pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.51%

5.2 History

The dividend of GPI is nicely growing with an annual growth rate of 20.80%!
Dividend Growth(5Y)20.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

23.56% of the earnings are spent on dividend by GPI. This is a low number and sustainable payout ratio.
The dividend of GPI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.56%
EPS Next 2Y42.34%
EPS Next 3YN/A
GPI.MI Yearly Income VS Free CF VS DividendGPI.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
GPI.MI Dividend Payout.GPI.MI Dividend Payout, showing the Payout Ratio.GPI.MI Dividend Payout.PayoutRetained Earnings

GPI SPA

BIT:GPI (7/25/2025, 7:00:00 PM)

15.44

+1.22 (+8.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.87%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap446.37M
Analysts82.86
Price Target17 (10.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.51%
Yearly Dividend0.85
Dividend Growth(5Y)20.8%
DP23.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE 4.3
Fwd PE 20.45
P/S 0.9
P/FCF N/A
P/OCF 12.43
P/B 1.45
P/tB N/A
EV/EBITDA 8.43
EPS(TTM)3.59
EY23.25%
EPS(NY)0.75
Fwd EY4.89%
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)1.24
OCFY8.05%
SpS17.17
BVpS10.67
TBVpS-2.59
PEG (NY)0.1
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 33.74%
ROCE 6.05%
ROIC 4.54%
ROICexc 5.01%
ROICexgc 16.53%
OM 7.4%
PM (TTM) 20.96%
GM 71.31%
FCFM N/A
ROA(3y)4.3%
ROA(5y)3.67%
ROE(3y)13.36%
ROE(5y)13.06%
ROIC(3y)3.61%
ROIC(5y)4.65%
ROICexc(3y)4.36%
ROICexc(5y)6.05%
ROICexgc(3y)13.88%
ROICexgc(5y)19.65%
ROCE(3y)4.81%
ROCE(5y)6.2%
ROICexcg growth 3Y-14.64%
ROICexcg growth 5Y-1.41%
ROICexc growth 3Y-17.1%
ROICexc growth 5Y-8.15%
OM growth 3Y0.35%
OM growth 5Y3.23%
PM growth 3Y83.16%
PM growth 5Y39.62%
GM growth 3Y-0.12%
GM growth 5Y0.09%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA 2.72
Cap/Depr 96.85%
Cap/Sales 10.35%
Interest Coverage 1.8
Cash Conversion 40%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.32
Altman-Z 1.32
F-Score5
WACC5.96%
ROIC/WACC0.76
Cap/Depr(3y)122.12%
Cap/Depr(5y)103.13%
Cap/Sales(3y)11.48%
Cap/Sales(5y)9.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1789.47%
EPS 3Y80.87%
EPS 5Y43.78%
EPS Q2Q%169.57%
EPS Next Y44.86%
EPS Next 2Y42.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.92%
Revenue growth 3Y15.3%
Revenue growth 5Y15.94%
Sales Q2Q%9.98%
Revenue Next Year6.47%
Revenue Next 2Y6.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.41%
EBIT growth 3Y15.71%
EBIT growth 5Y19.69%
EBIT Next Year176.63%
EBIT Next 3Y47.95%
EBIT Next 5YN/A
FCF growth 1Y50.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.66%
OCF growth 3Y41.24%
OCF growth 5Y24.83%